Submitted by Anonymous (not verified) on 30 April 2024 - 12:03
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 22, Status: Authorised